483 Novartis Pharmaceuticals Jul 2015

483 Novartis Pharmaceuticals Jul 2015

Darren Brown FDA, Lucila Nwatu FDA, Robert Tollefsen FDA$119.00 - Available Now

FDA investigators audited the Novartis Pharmaceuticals - San Carlos, CA, United States facility and issued 5 inspectional observations (via FDA 483) on 17 Jul 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 5
  • Inspection end: 17 Jul 2015
  • Location: San Carlos, United States
  • FEI: 3007886374
Add To Cart